Sectors
MBX
MBX Biosciences, Inc.
61.60
2 x 44.92
2 x 77.33
bid
ask
-
1.40
2.22%
2 @ 07:30 PM
61.60 +0.00 (0.00%)
| Ytd | 95.31% | |
| 1y | 308.22% |
59.47
day range
63.04
9.63
52 week range
72.64
| Open | 62.30 | Prev Close | 63.00 | Low | 59.47 | High | 63.04 | Mkt Cap | 2.97B |
| Vol | 518.30K | Avg Vol | 752.69K | EPS | -2.37 | P/E | N/A | Forward P/E | -15.57 |
| Beta | 0.10 | Short Ratio | 8.26 | Inst. Own | 115.75% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 61.50 | 200-d Avg | 39.80 | 1yr Est | 88.36 |
| Income Statement | |||
| Operating Expenses | 40.93M | ||
| Research and Development Expense | 30.99M | ||
| Selling, General and Administrative Expense | 9.95M | ||
| Operating Income | -40.93M | ||
| Net Income | -37.09M | ||
| Net Income Common Stock | -37.09M | ||
| Net Income Common Stock (USD) | -37.09M | ||
| Consolidated Income | -37.09M | ||
| Earnings per Basic Share | -0.78 | ||
| Earnings per Basic Share (USD) | -0.78 | ||
| Earnings per Diluted Share | -0.78 | ||
| Earning Before Interest & Taxes (EBIT) | -37.09M | ||
| Earning Before Interest & Taxes (USD) | -37.09M | ||
| Weighted Average Shares | 47.70M | ||
| Weighted Average Shares Diluted | 47.70M | ||
| Balance Sheet | |||
| Cash and Equivalents | 54.12M | ||
| Cash and Equivalents (USD) | 54.12M | ||
| Investments | 364.46M | ||
| Investments Current | 364.46M | ||
| Current Assets | 427.86M | ||
| Property, Plant & Equipment Net | 7.42M | ||
| Total Assets | 435.91M | ||
| Debt Current | 631.00K | ||
| Total Debt | 3.34M | ||
| Current Liabilities | 23.66M | ||
| Debt Non-Current | 2.71M | ||
| Total Liabilities | 26.37M | ||
| Accumulated Retained Earnings (Deficit) | -285.09M | ||
| Accumulated Other Comprehensive Income | -1.22M | ||
| Shareholders Equity | 409.54M | ||
| Shareholders Equity (USD) | 409.54M | ||
| Assets Non-Current | 8.05M | ||
| Total Debt (USD) | 3.34M | ||
| Liabilities Non-Current | 2.71M | ||
| Trade and Non-Trade Payables | 4.36M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 199.00K | ||
| Net Cash Flow from Financing | 2.32M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 8.91M | ||
| Capital Expenditure | -901.00K | ||
| Issuance (Purchase) of Equity Shares | 2.45M | ||
| Net Cash Flow from Investing | 29.21M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 30.11M | ||
| Net Cash Flow from Operations | -22.62M | ||
| Share Based Compensation | 6.06M | ||